Answer
May 20, 2025 - 12:37 PM
Rinvoq (upadacitinib) is a medication used to treat several inflammatory conditions. It is primarily prescribed for moderate to severe rheumatoid arthritis in adults who have not responded well to other treatments. Additionally, Rinvoq is approved for use in treating psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, and ulcerative colitis, depending on the specific regulatory approvals in various regions.
